Literature DB >> 23677098

Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma.

Jeffrey R Hamilton, Rupa Parvataneni, Sarah E Stuart, Mary-Margaret Chren.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23677098      PMCID： PMC3733327          DOI： 10.1001/jamadermatol.2013.3339

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  Recurrence rates of treated basal cell carcinomas. Part 1: Overview.

Authors:  M K Silverman; A W Kopf; C M Grin; R S Bart; M J Levenstein
Journal:  J Dermatol Surg Oncol       Date:  1991-09

2.  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.

Authors:  Igal Leibovitch; Shyamala C Huilgol; Dinesh Selva; Dudley Hill; Shawn Richards; Robert Paver
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

3.  Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic.

Authors:  Mary-Margaret Chren; Anju P Sahay; Laura P Sands; Leah Maddock; Karla Lindquist; Daniel Bertenthal; Peter Bacchetti
Journal:  Med Care       Date:  2004-10       Impact factor: 2.983

4.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.

Authors:  Klara Mosterd; Gertruud A M Krekels; Fred Hm Nieman; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Peter M Steijlen; Anton Vermeulen; Ham Neumann; Nicole W J Kelleners-Smeets
Journal:  Lancet Oncol       Date:  2008-11-17       Impact factor: 41.316

5.  Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Eleni Linos; Jeanette S Torres; Sarah E Stuart; Rupa Parvataneni; W John Boscardin
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551
  5 in total
  2 in total

1.  Response to Rogers et al.

Authors:  Robert S Stern
Journal:  J Invest Dermatol       Date:  2013-10-30       Impact factor: 8.551

Review 2.  Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations.

Authors:  Shalini V Mohan; Anne Lynn S Chang
Journal:  Curr Dermatol Rep       Date:  2014-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.